首页> 美国卫生研究院文献>Pharmaceutics >Novel Gastroretentive Floating Pulsatile Drug Delivery System Produced via Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing
【2h】

Novel Gastroretentive Floating Pulsatile Drug Delivery System Produced via Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing

机译:通过热熔挤出和熔融沉积建模3D打印生产的新型胃滞留浮动脉动药物递送系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study was performed to develop novel core-shell gastroretentive floating pulsatile drug delivery systems using a hot-melt extrusion-paired fused deposition modeling (FDM) 3D printing and direct compression method. Hydroxypropyl cellulose (HPC) and ethyl cellulose (EC)-based filaments were fabricated using hot-melt extrusion technology and were utilized as feedstock material for printing shells in FDM 3D printing. The directly compressed theophylline tablet was used as the core. The tablet shell to form pulsatile floating dosage forms with different geometries (shell thickness: 0.8, 1.2, 1.6, and 2.0 mm; wall thickness: 0, 0.8, and 1.6 mm; and % infill density: 50, 75, and 100) were designed, printed, and evaluated. All core-shell tablets floated without any lag time and exhibited good floating behavior throughout the dissolution study. The lag time for the pulsatile release of the drug was 30 min to 6 h. The proportion of ethyl cellulose in the filament composition had a significant ( < 0.05) effect on the lag time. The formulation (2 mm shell thickness, 1.6 mm wall thickness, 100% infill density, 0.5% EC) with the desired lag time of 6 h was selected as an optimized formulation. Thus, FDM 3D printing is a potential technique for the development of complex customized drug delivery systems for personalized pharmacotherapy.
机译:进行了这项研究,以开发使用热熔挤出配对熔融沉积建模(FDM)3D打印和直接压缩方法的新型核壳胃肠滞留浮动脉动药物递送系统。羟丙基纤维素(HPC)和乙基纤维素(EC)基的长丝是使用热熔挤出技术制造的,并用作FDM 3D打印中打印外壳的原料。将直接压制的茶碱片用作核心。制成具有不同几何形状(外壳厚度:0.8、1.2、1.6和2.0毫米;壁厚:0、0.8和1.6毫米;填充密度百分比:50、75和100)的片剂外壳,形成搏动性漂浮剂型设计,打印和评估。在整个溶出度研究中,所有核壳片剂均漂浮而没有任何滞后时间,并且表现出良好的漂浮行为。脉冲释放药物的滞后时间为30分钟至6小时。长丝组合物中乙基纤维素的比例对滞后时间有显着影响(<0.05)。选择所需滞后时间为6小时的配方(2毫米壳厚,1.6毫米壁厚,100%填充密度,0.5%EC)作为优化配方。因此,FDM 3D打印是开发用于个性化药物治疗的复杂定制药物输送系统的潜在技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号